James Lougheed - May 24, 2021 Form 4 Insider Report for MAXLINEAR INC (MXL)

Signature
/s/ Connie Kwong, as Attorney-in-Fact
Stock symbol
MXL
Transactions as of
May 24, 2021
Transactions value $
-$1,281,708
Form type
4
Date filed
5/26/2021, 06:57 PM
Previous filing
Jun 2, 2021
Next filing
Jun 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Options Exercise $317K +24.3K +28.23% $13.03 110K May 24, 2021 Direct
transaction MXL Common Stock Sale -$881K -24.3K -22.02% $36.29 86K May 24, 2021 Direct F1
transaction MXL Common Stock Options Exercise $87.8K +6.74K +7.83% $13.03 92.8K May 25, 2021 Direct
transaction MXL Common Stock Options Exercise $190K +15.6K +16.84% $12.17 108K May 25, 2021 Direct
transaction MXL Common Stock Options Exercise $104K +7.64K +7.05% $13.61 116K May 25, 2021 Direct
transaction MXL Common Stock Sale -$1.1M -30K -25.85% $36.62 86K May 25, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXL Stock Option (right to buy) Options Exercise $0 -2.53K -100% $0.00* 0 May 24, 2021 Common Stock 2.53K $13.03 Direct F3
transaction MXL Stock Option (right to buy) Options Exercise $0 -21.8K -76.35% $0.00 6.74K May 24, 2021 Common Stock 21.8K $13.03 Direct F4
transaction MXL Stock Option (right to buy) Options Exercise $0 -6.74K -100% $0.00* 0 May 25, 2021 Common Stock 6.74K $13.03 Direct F4
transaction MXL Stock Option (right to buy) Options Exercise $0 -15.6K -100% $0.00* 0 May 25, 2021 Common Stock 15.6K $12.17 Direct F5
transaction MXL Stock Option (right to buy) Options Exercise $0 -7.64K -32.55% $0.00 15.8K May 25, 2021 Common Stock 7.64K $13.61 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 24,292 shares sold in the price range of $36.08 to $36.59 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Represents the weighted average share price of an aggregate total of 30,000 shares sold in the price range of $36.16 to $37.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Subject to the Reporting Person continuing to provide services to the Company through each applicable vesting date, the option shall vest as follows: (i) beginning on May 14, 2017 (the "Vesting Commencement Date) and through December 14, 2017, 11.452% of the shares subject to the option vest and become exercisable in equal monthly installments over such period on the same day of the month as the Vesting Commencement Date, (ii) beginning on January 14, 2018 and through December 14, 2018, 28.015% of the shares subject to the option shall vest and become exercisable in equal monthly installments over such period on the same day of the month as the Vesting Commencement Date, and (iii) beginning on January 14, 2019 and through December 14, 2019, 60.533% of the shares subject to the option shall vest and become exercisable in equal monthly installments on the same day of the month as the Vesting Commencement Date.
F4 Subject to the Reporting Person continuing to provide services to the Company through each applicable vesting date, the option shall vest as follows: (i) beginning on May 14, 2017 (the "Vesting Commencement Date) and through December 14, 2017, 34.77% of the shares subject to the option vest and become exercisable in equal monthly installments over such period on the same day of the month as the Vesting Commencement Date, (ii) beginning on January 14, 2018 and through December 14, 2018, 47.32% of the shares subject to the option shall vest and become exercisable in equal monthly installments over such period on the same day of the month as the Vesting Commencement Date, and (iii) beginning on January 14, 2019 and through September 14, 2019, 17.91% of the shares subject to the option shall vest and become exercisable in equal monthly installments over such period on the same day of the month as the Vesting Commencement Date.
F5 Subject to the Reporting Person continuing to provide services to the Company through each applicable vesting date, one thirty-third (1/33rd) of the shares subject to the option vested and became exercisable on June 1, 2017 (the "Vesting Commencement Date), and one thirty-third (1/33rd) of the shares subject to the option shall vest and become exercisable each month thereafter on the same day of the month as the Vesting Commencement Date.
F6 Subject to the Reporting Person continuing to provide services to the Company through each applicable vesting date, one thirty-first (1/31st) of the shares subject to the option vested and became exercisable on June 2, 2017 (the "Vesting Commencement Date), and one thirty-first (1/31st) of the shares subject to the option shall vest and become exercisable each month thereafter on the same day of the month as the Vesting Commencement Date.

Remarks:

Vice President, Marketing, High Performance Analog